Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

[1]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice , 1994 .

[2]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, European heart journal.

[3]  C. Furberg,et al.  Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.

[4]  M-heart investigators.  Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS) , 1994, The Lancet.

[5]  D. Illingworth,et al.  Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin , 1994, The Lancet.

[6]  N J Wald,et al.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? , 1994, BMJ.

[7]  R. Collins,et al.  Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. , 1994, European heart journal.

[8]  J. Albers,et al.  Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease , 1993, Circulation.

[9]  J. Tijssen,et al.  Retardation and arrest of progression or regression of coronary artery disease: a review. , 1993, Progress in cardiovascular diseases.

[10]  T. Craven,et al.  Prognostic Significance of Progression of Coronary Atherosclerosis , 1993, Circulation.

[11]  U. Ravnskov,et al.  Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. , 1992, BMJ.

[12]  V. Salomaa,et al.  Acute myocardial infarction (AMI) in Finland--baseline data from the FINMONICA AMI register in 1983-1985. , 1992, European heart journal.

[13]  G. Davey Smith,et al.  Should there be a moratorium on the use of cholesterol lowering drugs? , 1992, BMJ.

[14]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[15]  M. Davies,et al.  Atherosclerosis: inhibition of regression as therapeutic possibilities. , 1991, British heart journal.

[16]  B. Rifkind,et al.  The value of lowering cholesterol after myocardial infarction. , 1990, The New England journal of medicine.

[17]  J P Matts,et al.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.

[18]  K. Goa,et al.  Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. , 1990, Drugs.

[19]  K. Matthews,et al.  Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. , 1990, BMJ.

[20]  R J Prineas,et al.  A new epidemiologic classification system for interim myocardial infarction from serial electrocardiographic changes. , 1989, The American journal of cardiology.

[21]  J. Stamler,et al.  Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.

[22]  D. Grafnetter,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. , 1978, British heart journal.

[23]  W. Martin,et al.  Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. , 1978, Journal of chronic diseases.

[24]  G. Rosenhamer,et al.  Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid. , 1977, Atherosclerosis.

[25]  J. Stamler.  Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[26]  P. Leren.  The Oslo Diet‐Heart Study: Eleven‐Year Report , 1970, Circulation.